Year All202620252024202320222021202020192018201720162015201420122011 Jan 3, 2017 Ardelyx Announces Presentation at J.P. Morgan 35th Annual Healthcare Conference Nov 7, 2016 Ardelyx Reports Third Quarter 2016 Financial Results and Recent Progress Oct 31, 2016 Ardelyx to Announce Third Quarter 2016 Financial Results on November 7, 2016 Oct 24, 2016 Ardelyx Strengthens Executive Leadership with the Appointment of Reginald Seeto, MBBS, as Chief Operating Officer Oct 19, 2016 Ardelyx Announces the Presentation of Positive Global Endpoint Findings from Phase 2b Trial of Tenapanor in Patients with IBS-C at ACG Annual Meeting Sep 22, 2016 Ardelyx to Present at Ladenburg Thalmann 2016 Healthcare Conference Aug 15, 2016 Ardelyx to Present at Wedbush PacGrow Healthcare Conference Aug 8, 2016 Ardelyx Reports Second Quarter 2016 Financial Results Aug 1, 2016 Ardelyx to Report Second Quarter 2016 Financial Results on August 8th, 2016 Aug 1, 2016 Ardelyx Receives Notice of Allowance of Composition of Matter Patent Covering its Novel Potassium Binder RDX227675